HANNAH BANGURA: Open Payments
NPI 1801219449 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 10 payments from 6 companies in 2025. Trend: 2023 $389 · 2024 $353 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $377 |
| PROTEGA PHARMACEUTIALS INC | 1 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Abbott Laboratories | 1 | $15 |
Products named: LYBALVI, ARISTADA, ROXYBOND, INGREZZA, AUSTEDO XR, COBENFY, ETERNA.
Industry payments across AZ — which companies pay providers there.
